4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-25-007313
EVP R&D, Chief Medical Officer gave up 3,049 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 6,866 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-26 | Exercise or conversion : show line 1 in the form | +6,866 | 80,789 | D | ||
| 2025-02-26 | Shares withheld for taxes : show line 2 in the form | −3,049 | $34.80 | $106,090 | 77,740 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-26 | Exercise or conversion : show line 3 in the form Restricted Stock Unit Award | −6,866 | 20,598 | D |
Loading xslF345X05/form4.xml…